Philips New Orders Rise on Robust Demand in North America (2)

Nov. 4, 2025, 8:03 AM UTC

Royal Philips NV’s order intake climbed 8% in the third quarter amid robust demand for the manufacturer’s medical devices in North America.

Adjusted earnings before interest, taxes and amortization also increased in the period, to €531 million ($611 million), as sales grew and efficiency measures took effect, the Dutch company said Tuesday. Tariff expenses prevented an even better result.

Philips reiterated its financial outlook for the year and specified that it now expects its adjusted Ebita margin to come in at the upper end of the guided 11.3% to 11.8% range.

“We have been taking very strong measures both ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.